ArticleBMJ public health2026
National prioritisation of zoonotic diseases in Rwanda: a One Health modified Delphi consensus study.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Quadripartite One Health Joint Plan of Action and the WHO's Pandemic Agreement emphasise operationalising the One Health (OH) approach to strengthen global preparedness, prevention and response to emerging health threats. In line with these global commitments, Rwanda has developed a national One Health Strategic Plan to enhance multisectoral collaboration across the human, animal and environmental health sectors. However, effective implementation requires substantial investment in integrated surveillance, preparedness and response systems, highlighting the need for an evidence-based prioritisation framework to guide resource mobilisation and strategic allocation. This exercise aimed to prioritise zoonotic diseases of public health importance in Rwanda using criteria including disease burden, outbreak potential, morbidity and mortality, socioeconomic impact, availability of diagnostic tools, transboundary risk and the effectiveness of prevention and control measures. Methods: A modified Delphi approach was employed, consisting of (1) a planning phase to develop prioritisation criteria and survey instruments, (2) two rounds of expert surveys and (3) a consensus-building workshop using Mentimeter for anonymous voting. All the activities were conducted in Kigali, Rwanda. 25 experts representing the Ministries of Health, Agriculture and Environment; national regulatory agencies; the Rwanda Agriculture and Animal Resources Development Board; Rwanda Wildlife Conservation, Gorilla Doctors; the University of Rwanda; the University of Global Health Equity and development partners including Igisekuruza Tree (iGiTREE), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) and United States Agency for International Development (USAID) participated. Additional technical support was provided by the Pan-African One Health Institute. Results: Rabies, zoonotic tuberculosis and toxoplasmosis emerged as the highest-priority zoonotic diseases within their respective categories. Participants identified limited transdisciplinary training opportunities, inadequate sustainable financing mechanisms and insufficient data integration across sectors as key barriers to effective OH implementation. Conclusion: Strengthening integrated surveillance systems, improving multisectoral data sharing and investing in a competent OH workforce are critical for enhancing preparedness against priority zoonoses. Furthermore, regular prioritisation exercises will ensure that disease rankings remain current and responsive to evolving risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.